Markets:

Overview

News

Currencies

International

Treasuries

Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

3.010 -0.230 (-7.10%)

Streaming Delayed Price Updated: 12:01 PM EDT, May 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rezolute, Inc. - Common Stock (NV)

< Previous 1 2 3 4 5 6 7 Next >

Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants

June 13, 2024

From Rezolute, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 13, 2024

Via Benzinga

Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

June 13, 2024

From Rezolute, Inc.

Via GlobeNewswire

RZLT Stock Earnings: Rezolute Misses EPS for Q3 2024 ↗

May 15, 2024

RZLT stock results show that Rezolute missed analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Rezolute Inc. (NASDAQ: RZLT) Climbs to New 52-Week High

April 15, 2024

Via Investor Brand Network

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 05, 2024

Via Benzinga

Rezolute to Participate in the Jefferies Global Healthcare Conference

May 30, 2024

From Rezolute, Inc.

Via GlobeNewswire

Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

May 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 22, 2024

Via Benzinga

Why Is Small-Cap Metabolic-Focused Rezolute Stock Trading Higher On Wednesday? ↗

May 22, 2024

Rezolute announced topline results from the Phase 2 study of RZ402 for diabetic macular edema, showing significant improvements in macular edema and a favorable safety profile.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 22, 2024

Pre-market stock movers are worth checking out on Wednesday as we offer up all the latest news sending shares higher and lower this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 21, 2024

Via Benzinga

Rezolute Reports Positive Topline Results from Phase 2 Proof of Concept Study of RZ402 in Patients with Diabetic Macular Edema (DME)

May 21, 2024

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update

May 15, 2024

From Rezolute, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 23, 2024

Via Benzinga

Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting

April 23, 2024

From Rezolute, Inc.

Via GlobeNewswire

Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? ↗

April 15, 2024

Discover three biotech stocks with explosive growth potential. Don't miss out on these great picks this year.

Via InvestorPlace

CommScope Holding And 2 Other Stocks Under $3 Insiders Are Buying ↗

April 01, 2024

The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

3 Stocks Insiders Are Buying That Analysts Love

March 26, 2024

Insiders are buying these stocks that analysts view as undervalued. Each has a potential catalyst in the works, and its shares could advance triple digits.

Via MarketBeat

$17M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

March 20, 2024

The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

$1.5M Bet On This Penny Stock? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying ↗

March 11, 2024

The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)

March 06, 2024

Potential to more than double the addressable patient population living with hypoglycemia resulting from insulin receptor over-activation (tumor hyperinsulinism)

From Rezolute, Inc.

Via GlobeNewswire

Lumen Technologies And 3 Other Stocks Under $3 Insiders Are Buying ↗

February 28, 2024

The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying ↗

February 22, 2024

The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Rezolute And 3 Other Penny Stocks Insiders Are Buying ↗

February 21, 2024

The Dow Jones index closed lower by more than 60 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update

February 13, 2024

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial Officer

January 24, 2024

From Rezolute, Inc.

Via GlobeNewswire

Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

January 23, 2024

From Rezolute, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Rezolute, Inc. - Common Stock (NV) (NQ:RZLT)

All News about Rezolute, Inc. - Common Stock (NV)

Starting at $3.75/week.

Subscribe Today